US Patent 12071456 Extended recombinant polypeptides and compositions comprising same
Patent 12071456 was granted and assigned to Amunix Pharmaceuticals, Inc. on August, 2024 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 12071456 Extended recombinant polypeptides and compositions comprising same
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
